# Did Colossal Actually Clone Red Wolves, or Is This a Stunt?

According to MIT Technology Review, Colossal Biosciences produced red wolf clones from cryopreserved somatic cells, using the same somatic cell nuclear transfer technique that created Dolly the sheep. The January field visit described in the report shows two young scientists, including Tanner Broussard, caring for the animals in a Houston-area facility. The clones are genetically identical to a male red wolf whose cells were banked decades ago, giving conservationists a genetic rescue option that didn't exist before. The technical details matter here. Colossal said the cloning succeeded on the first attempts, which would be remarkable given that red wolves have never been cloned before. But MIT Technology Review reported that the company has not yet published peer-reviewed data on the clones' health, fertility, or behavioral development. Without that evidence, the announcement is a claim, not a proven result.

# Why Are Red Wolves in Such Dire Straits That Cloning Seems Necessary?

According to the US Fish and Wildlife Service's Red Wolf Recovery Program, the wild population has collapsed from a peak of 120 animals in 2012 to fewer than 20 today. The species was declared extinct in the wild in 1980, then reintroduced in eastern North Carolina in 1987. But gunshot mortality, vehicle strikes, and hybridization with coyotes have decimated the population. The agency reported that only 13 known wild red wolves were confirmed in 2025, making every individual genetically precious. This is where cloning becomes more than a novelty. The captive population of roughly 250 red wolves is genetically bottlenecked, with many animals sharing recent ancestors. A clone derived from a genetically valuable historical individual could inject new diversity into the breeding pool. That's the argument Colossal is making: not that clones will replace wild wolves, but that they'll strengthen the captive population enough to make reintroduction viable again.

# What Does the US Fish and Wildlife Service Actually Think About This?

The US Fish and Wildlife Service has not endorsed Colossal's cloning program. The agency's Red Wolf Recovery Plan, updated in 2023, focuses on habitat protection, coyote sterilization, and community engagement — not on cloning. The service said in its 2025 status report that genetic rescue through assisted reproduction is a "potential tool," but the agency hasn't committed to accepting clones into its managed breeding program. This is a critical gap. Colossal can clone wolves, but it cannot release them into the wild without federal approval. The species is protected under the Endangered Species Act, and any reintroduction requires a formal plan. According to MIT Technology Review, Colossal has not yet submitted a proposal to the Fish and Wildlife Service for integrating clones into the recovery program. That means the clones are currently a scientific demonstration, not a conservation intervention.

# How Do Colossal's Clones Compare to Traditional Red Wolf Recovery Efforts?

Approach	Cost per Animal	Time to Wild Release	Genetic Diversity Impact	Proven Success
Colossal Cloning	High (est. $500K+)	3-5 years minimum	High potential, unproven	None in red wolves
Captive Breeding	Moderate	1-3 years	Limited by existing gene pool	Proven but insufficient
Wild Population Management	Low per animal	Immediate	Preserves existing diversity	Partially successful until 2012
Verdict	Cloning adds genetic value but cannot replace habitat protection and anti-poaching enforcement. The US Fish and Wildlife Service's traditional recovery tools remain the only proven path to wild population recovery.

# What Would Have to Happen for These Clones to Actually Matter?

For Colossal's red wolf clones to contribute to conservation, three things must happen in sequence. First, the clones must reach sexual maturity and breed successfully with non-cloned wolves, proving they're not just viable but fertile. Second, the US Fish and Wildlife Service must accept the offspring into its Species Survival Plan, which requires genetic screening and health certifications. Third, the resulting animals must survive in a managed wild setting, which means the agency must designate new reintroduction sites — a politically fraught process. MIT Technology Review's field report shows the clones are healthy at several months old, but that's the easy part. Red wolves in captivity live 12-14 years, and no one has yet demonstrated that a cloned canid can navigate the social complexities of wolf pack life. The company would need to show that its clones can form pair bonds, raise pups, and avoid inbreeding with close relatives — behaviors that emerge over years, not months.

# My Predictions for Colossal's Red Wolf Program

1. By December 2027, Colossal Biosciences will announce a successful pregnancy from a cloned red wolf female, but the offspring will remain in captivity due to unspecified "regulatory requirements." 2. The US Fish and Wildlife Service will not formally integrate cloned red wolves into its Species Survival Plan before 2028, citing insufficient peer-reviewed data on long-term health and behavior. 3. Colossal will pivot its red wolf program toward "genetic rescue" of captive populations rather than wild reintroduction, acknowledging that habitat loss and poaching remain the binding constraints.